In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Q-Med's Second Gamble

Executive Summary

Q-Med is looking to solve two big problems of the disease management business: creating a proprietary hook and selling cost-benefit results to managed care plans which fit within their very short time horizons. The company believes and has evidence that their coronary artery disease monitor can identify patients who will have a heart attack or require some serious medical intervention within the one-to two year time frame of managed care plans.
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV000434

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel